CLINICAL PROFILE AND OUTCOME OF CEREBRAL MALARIA IN A TERTIARY CARE HOSPITAL, KARACHI
DOI:
https://doi.org/10.71000/1d26tn36Keywords:
Cerebral malaria, complications, prognosis, neurological sequelae, mortality, Acute Kidney Injury, Plasmodium falciparumAbstract
Background: Cerebral malaria (CM), a severe neurological complication of Plasmodium falciparum infection, remains a major cause of morbidity and mortality in endemic regions. Despite global progress in diagnosis and treatment, CM continues to pose a serious threat in low-resource urban settings such as Karachi, Pakistan, where high population density, inadequate vector control, and delays in medical care increase the disease burden. Early recognition and effective management are crucial to reducing fatal outcomes and long-term neurological sequelae.
Objective: The objective of this study was to assess the clinical presentations, complications, and outcomes of patients with CM at Jinnah Postgraduate Medical Centre (JPMC), Karachi, and to identify predictors of poor prognosis.
Methods: A cross-sectional study was conducted over six months and included 71 patients diagnosed with CM and admitted to Wards 5, 6, 7, and 23 of JPMC. Inclusion criteria required patients to be above 18 years with confirmed Plasmodium falciparum positivity by peripheral blood smear or antigen test. Data were obtained from structured proformas, hospital records, and ward registers. Information on demographics, presenting features, complications, laboratory investigations, treatment received (intravenous fluids, artesunate, quinine), and outcomes was recorded. Statistical analysis was carried out using SPSS; chi-square tests were applied to categorical variables, and independent-sample t-tests were used for continuous variables, with significance set at p<0.05.
Results: Of the 71 patients, 50 (70%) were male and 21 (30%) female. The most affected age group was 21–30 years (37%), followed by 18–20 years (25%). Clinical features included fever in 68 patients (95%), altered consciousness in 60 (85%), coma in 53 (75%), weakness in 57 (80%), and seizures in 29 (41%). Complications recorded were hypoglycemia in 32 (45%), acute kidney injury in 28 (40%), multi-organ failure in 14 (20%), neurological sequelae in 21 (30%), hepatic dysfunction in 7 (10%), and sepsis in 15 (21%). All patients received intravenous fluids, while 60 (85%) were treated with artesunate and 11 (15%) with quinine. Thirty-five (50%) required ICU admission, 18 (25%) needed mechanical ventilation, and 15 (21%) underwent blood transfusion. In terms of outcomes, 50 (70%) recovered completely, 15 (21%) developed neurological sequelae, and 6 (9%) died. Mortality was significantly associated with prolonged coma (p=0.02) and extended hospital stay (p=0.04).
Conclusion: The findings demonstrate that cerebral malaria in Karachi remains a critical public health issue with high rates of complications and neurological sequelae despite standard treatment. Prolonged coma and multi-organ involvement were strong predictors of poor prognosis. Timely diagnosis, prompt initiation of therapy, and improved critical care facilities are essential to reducing mortality. Further research on adjunctive therapies is warranted to mitigate long-term neurological damage.
References
Fida, M., Li, P., Wang, Y., Alam, S. K., & Nsabimana, A. (2023). Water contamination and human health risks in Pakistan: a review. Exposure and Health, 15(3), 619-639.
Ibrahim, O. R., Issa, A., Babatunde, R. T., & Alao, M. A. (2024). Clinical and laboratory predictors of poor outcomes in pediatric cerebral malaria in Nigeria. Oman Medical Journal, 39(6), e692.
Jain, Y., Kataria, A., & Singh, M. (2024). Cerebral and other Forms of Severe Malaria. Product Innovation & Entrepreneurship, 414.
Khan, M., Nisar, H., & Mushahid, N. (2021). Clinical and Lab profile of severe and uncomplicated malaria: A prospective study from Khuzdar Balochistan. Pakistan Journal of Medical Sciences, 37(7), 1918.
Muppidi, P., Wright, E., Wassmer, S. C., & Gupta, H. (2023). Diagnosis of cerebral malaria: Tools to reduce Plasmodium falciparum associated mortality. Frontiers in cellular and infection microbiology, 13, 1090013.
Organization, W. H. (2023). WHO malaria policy advisory group (MPAG) meeting report, 18–20 April 2023. World Health Organization.
Schiess, N., Villabona-Rueda, A., Cottier, K. E., Huether, K., Chipeta, J., & Stins, M. F. (2020). Pathophysiology and neurologic sequelae of cerebral malaria. Malaria journal, 19(1), 266.
Song, X., Wei, W., Cheng, W., Zhu, H., Wang, W., Dong, H., & Li, J. (2022). Cerebral malaria induced by plasmodium falciparum: clinical features, pathogenesis, diagnosis, and treatment. Frontiers in cellular and infection microbiology, 12, 939532.
Trivedi, S., & Chakravarty, A. (2022). Neurological complications of malaria. Current neurology and neuroscience reports, 22(8), 499-513.
Mangal P, Mittal S, Kachhawa K, Agrawal D, Rath B, Kumar S. Analysis of the Clinical Profile in Patients with Plasmodium falciparum Malaria and Its Association with Parasite Density. J Glob Infect Dis. 2017;9(2):60-5.
Bi D, Lin J, Luo X, Lin L, Tang X, Luo X, et al. Biochemical characteristics of patients with imported malaria. Front Cell Infect Microbiol. 2022;12:1008430.
Royo J, Rahabi M, Kamaliddin C, Ezinmegnon S, Olagnier D, Authier H, et al. Changes in monocyte subsets are associated with clinical outcomes in severe malarial anaemia and cerebral malaria. Sci Rep. 2019;9(1):17545.
Khan M, Nisar H, Mushahid N. Clinical and Lab profile of severe and uncomplicated malaria: A prospective study from Khuzdar Balochistan. Pak J Med Sci. 2021;37(7):1918-23.
Naik H, Acharya A, Rout S. Clinical Profile and Treatment Outcomes of Patients with Malaria Complicated by Acute Kidney Injury. Saudi J Kidney Dis Transpl. 2023;34(2):117-24.
Koshy JM, Koshy J. Clinical profile of cerebral malaria at a secondary care hospital. J Family Med Prim Care. 2014;3(1):54-7.
Nadkar MY, Huchche AM, Singh R, Pazare AR. Clinical profile of severe Plasmodium vivax malaria in a tertiary care centre in Mumbai from June 2010-January 2011. J Assoc Physicians India. 2012;60:11-3.
Gehlawat VK, Arya V, Kaushik JS, Gathwala G. Clinical spectrum and treatment outcome of severe malaria caused by Plasmodium vivax in 18 children from northern India. Pathog Glob Health. 2013;107(4):210-4.
Sogbossi ES, Houekpetodji D, Kpadonou TG, Bleyenheuft Y. A Cross-sectional Study of the Clinical Profile of Children With Cerebral Palsy in Benin, a West African Low-Income Country. J Child Neurol. 2019;34(13):842-50.
Jain A, Kaushik R, Kaushik RM. Malarial hepatopathy: Clinical profile and association with other malarial complications. Acta Trop. 2016;159:95-105.
Dwivedi H, Singh SK, Chauhan BS, Gunjan S, Tripathi R. Potential cerebral malaria therapy: intramuscular arteether and vitamin D co-administration. Parasitology. 2016;143(12):1557-68.
Moussa EM, Huang H, Thézénas ML, Fischer R, Ramaprasad A, Sisay-Joof F, et al. Proteomic profiling of the plasma of Gambian children with cerebral malaria. Malar J. 2018;17(1):337.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Dharamveer, Shabnam Naveed, Uma Devi, Neha Rani (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.





